A sensitive and specific antigen detection assay for Middle East respiratory syndrome coronavirus

Since its emergence in 2012, more than 900 laboratory-confirmed cases of Middle East respiratory syndrome (MERS) have been reported with a fatality rate of more than 30%. However, no antigen detection assay for commercial use is available for diagnosis. In this study, the full-length nucleocapsid pr...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Yixin, Chan, Kwok-Hung, Kang, Yahong, Chen, Honglin, Luk, Hayes KH, Poon, Rosana WS, Chan, Jasper FW, Yuen, Kwok-Yung, Xia, Ningshao, Lau, Susanna KP, Woo, Patrick CY
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2015
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4575394/
https://www.ncbi.nlm.nih.gov/pubmed/26421268
http://dx.doi.org/10.1038/emi.2015.26

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4575394/
https://www.ncbi.nlm.nih.gov/pubmed/26421268
http://dx.doi.org/10.1038/emi.2015.26

Ejemplares similares